Farmacologa: Neumona

Adquirida en la Comunidad

Empirical antibiotic choice for adults

treated in the community
For patients treated in the community,
amoxicillin remains the preferred agent at a
dose of 500 mg three times daily. [A+]
Either doxycycline [D] or clarithromycin [A]
are appropriate as an alternative choice, and
for those patients who are hypersensitive to
penicillins.
Those with features of moderate or high
severity infection should be admitted urgently
to hospital. [C]

Gua IDSA
Outpatient

treatment 15. Previously healthy and

no risk factors for drug-resistant S. pneumoniae
(DRSP) infection: A. A macrolide (azithromycin,
clarithromycin, or erythromycin) (strong
recommendation; level I evidence) B.
Doxycycline (weak recommendation; level III
evidence)